Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by 11 memory and cognitive decline. It is incurable currently and places a great burden on the caregivers of 12 patients. Iron is rich in the brain of AD suffers. It catalyzes radicals which impairs neurons. Therefore, 
Introduction

43
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory and 44 cognitive decline [1] . It is incurable currently and places a great burden on the caregivers of patients [2] . 45 The cause of AD is not well understood. Many articles have demonstrated that increased oxidative 46 stress in AD brains may have a pathogenic role in neuronal degeneration; they impair membrane lipids 47 and proteins and ultimately result in neuronal death [3, 4] . 48 Iron is a transitional metal. It can catalyze free oxidative radical generation by deoxidizing oxygen 49 to oxyradicals or by donating electron to hydrogen peroxide, forming hydroxyl radicals [5] . Our previous 50 study revealed that AD brains have higher levels of iron than the normal brains, and the iron distribution 51 determines the regional density of radicals [6] . Therefore, reducing redundant iron in the brain may be an 52 option to ease AD. 53 Metal-chelators, such as desferrioxamine (DFO) and deferiprone (DFP), have been used as AD 54 treatments in clinical trials [7] . These agents have slowed the progression of AD in certain cases [8, 9] ; 55 however, the fundamental aspects of their biochemistry have severely limited their effectiveness. For 56 example, the hexadentate iron chelator DFO can cause fever, hearing loss and severe allergic reactions 57 [10]; the lipid-soluble iron chelator DFP can lower neutrophils and white blood cell count which causing 58 life-threatening infections [11, 12] . Therefore, designing or identifying a nontoxic iron chelator that 59 removes excessive iron from the brain is pressing. 60 Amyloid beta (Aβ) peptide consists of 36-43 amino acids and is cleaved by beta secretase from 61 amyloid precursor protein (APP) [13] . This peptide possesses high affinity Cu 2+ brain ( Fig. 1-A) . The topography ( Fig. 1-A approximately 300 nm in length ( Fig. 2 -B-c) and completely conformed to our design.
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Pure 5-HAYED oligomers display liner-like fibrils ( Fig. 2-B which displaying the stretching of the C=N bond in the imidazole ring of the histidine residue, were all 105 weakened ( Fig. 2-D (Fig. 3-A-a) . However, if 100 pM 5-HAYED was pre-added in the medium, the cells survived 110 with axons and dendrites extending and spines rich on dendrites (Fig. 3-A-b) . Furthermore, the cells 111 exhibit active cytoplasmic transport, for transport cysts can be seen along the dendrites (pointed by the 112 arrow in Fig. 3-A-b) . By contrast, in the iron-stressed cells, no transporting cysts can be found. It is 113 obviously that the iron-stress damaged the cell physiological activities. The wild aged KM mice, which were used as the Alzheimer's disease model, many neurons in the 120 cortex and hippocampus could be observed injured by Tunnel assay (indicating by the green spots in Fig.   121 4-A). The iron and hydroxy radical in the brain were 17 mM and 0.14 OD respectively, more than 70% 122 and 180% higher than that of the normal (Fig. 4-B) . However, when 5-HAYED was injected into the CSF, 123 the free iron and the hydroxy radical decreased to 12 mM and 0.07 OD respectively (Fig.4-B 
Discussion
154
Alzheimer's disease has a profound impact on patients, as well as their families and friends. The 5-HAYED peptide combined 5 times metal-pro amino residues histidine, glutamic acid and 
5-HAYED oligomers observation by TEM
212
The synthesized 5-HAYED powder was dissolved in distilled water (4 mg/ml) and divided to two with a one-site binding model using Origin, allowing for the association constant (Ka), enthalpy (ΔH), 225 and entropy (ΔS) of the interaction to be determined. Ka was used to calculate Kd (Kd=1/Ka). To confirm the 5-HAYED transgenic mouse, the whole DNA was extracted from the mouse tail. 
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Southern blot
274
The PCR products were electrophoresed on an agarose gel for separating by size. The DNA 275 fragments in the gel were then transferred to a sheet of nitrocellulose membrane and the membrane was 276 then exposed to a 5-HAYED hybridization probe (synthesized by Genepharm Ltd., Shanghai, China).
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After that, the membrane was washed for the excess probes removal and the pattern of hybridization is 278 visualized on X-ray film. 
Clinical chemistry
316
Clinical chemistry was performed to determine the side effects of 5-HAYED on the kidney or liver. 
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